Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction

American Heart Journal

Volumn 154, Issue 1, 2007, Pages 116-122

  Mrdovic, Igor Bogdan ^a   Savic, Lidija Zlatimir ^b   Perunicic, Jovan Petar ^a   Asanin, Milika Risto ^a   Lasica, Ratko Milorad ^a   Jelena, Marinkovic Milutin ^c   Matic, Mihailo Dragomir ^a   Vasiljevic, Zorana Mihailo ^a   Ostojic, Miodrag Caslav ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b Sci Veterinary Institute of Serbia   (Yugoslavia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; METOPROLOL; METOPROLOL TARTRATE; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; CAUSE OF DEATH; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METOPROLOL; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPANOLAMINES; QUALITY OF LIFE; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34250334724     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.03.049     Document Type: Article

References (38)

1. Hjalmarson A., Herlitz J., Málek I., et al. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomized trial. Lancet 318 (1981) 823-827
2. The MIAMI Trial Research Group. Metoprolol in Acute Myocardial Infarction (MIAMI): a randomized placebo controlled international trial. Eur Heart J 6 (1985) 199-226
3. ISIS-I (First International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-I. Lancet 328 (1986) 57-66
4. Beta-blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. Mortality results. JAMA 247 (1982) 1707-1714
5. Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304 (1981) 801-807
6. Mrdovic I. Is the level of evidence for the use of beta-blockers in acute myocardial infarction satisfactory enough? Letter to the editor. Eur Heart J 27 (2006) 118-119
7. Roberts R., Rogers W.J., Mueller H.S., et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) II-B study. Circulation 83 (1991) 422-437
8. COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet 366 (2005) 1622-1632
9. Freemantle N., Cleland J., Young P., et al. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318 (1999) 1730-1737
10. Gottlieb S., McCarter R., and Vogel R. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339 (1998) 489-497
11. Houghton T., Freemantle N., and Cleland J.G.F. Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials. Eur J Heart Fail 2 (2000) 333-340
12. Rouleau J.L., de Champlain J., Klein M., et al. Activation of neurohumoral systems in postinfarction left ventricular dysfunction. J Am Coll Cardiol 22 (1993) 390-398
13. Groenning B.A., Nilsson J.C., Sondergaard L., et al. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol 36 (2000) 2072-2080
14. Doughty R.N., Whalley G.A., Gamble G., et al. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol 29 (1997) 1060-1066
15. Quaife R.A., Gilbert E.M., Christian P.E., et al. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Am J Cardiol 78 (1996) 779-784
16. Bristow M.R., Gilbert E.M., Abraham W.T., et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 94 (1996) 2807-2816
17. Doughty R.N., Whalley G.A., Walsh H.A., et al. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction. The CAPRICORN Echo Substudy. Circulation 109 (2004) 201-206
18. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
19. Wollert K.C., and Drexler H. Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Trial: carvedilol as the sun and center of the beta-blocker world. Circulation 106 (2002) 2164-2166
20. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
21. Poole-Wilson P.A., Swedberg K., Cleland J.G.F., et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362 (2003) 7-13
22. Senior R., Basu S., Kinsey C., et al. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction. Am Heart J 137 (1999) 646-652
23. Basu S., Senior R., Raval U., et al. Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial. Circulation 96 (1997) 183-191
24. The CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial. Lancet 357 (2001) 1385-1390
25. Halkin A., Grines C.L., Cox D.A., et al. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction. J Am Coll Cardiol 43 (2004) 1780-1787
26. Kernis S.J., Harjai K.J., Stone G.W., et al. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?. J Am Coll Cardiol 43 (2004) 1773-1779
27. Ware J.E. SF-36 health survey manual and interpretation guide (1993), The Health Institute, New England Medical Center, Boston 1
28. Thompson D.R., and Yu C.M. Quality of life in patients with coronary heart disease-I: assessment review tools. Research health and quality of life outcomes vol. 1 (2003) 42
29. Bernstein J., Brook R.H., Werko L., et al. Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population. Heart 87 (2002) 140-145
30. Brown N., Melville M., Gray D., et al. Quality of life four years after acute myocardial infarction: short-form 36 scores compared with a normal population. Heart 81 (1999) 352-358
31. Gheorghiade M., and Goldstein S. Beta-blockers in the post-myocardial infarction patients. Circulation 106 (2002) 394-398
32. Sutton M.G.St.J., and Sharpe N. Left ventricular remodeling after myocardial infarction. Pathophysiology and therapy. Circulation 101 (2000) 2981
33. Borrello F., Beahan M., Klein L., et al. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period. Rev Cardiovasc Med 4 Suppl 3 (2003) S13-S24
34. Velazquez E.J., and Pfeffer M.A. Acute heart failure complicating acute coronary syndromes. A deadly intersection. Circulation 109 (2004) 440-442
35. Held P. Effects of beta blockers on ventricular dysfunction after myocardial infarction: tolerability and survival effects. Am J Cardiol 71 (1993) 39C-44C
36. Lopressor Intervention Trial Research Group. The Lopressor Intervention Trial: multicentre study of metoprolol in survivors of acute myocardial infarction. Eur Heart J 18 (1987) 1056-1064
37. Lopez-Sendon J., Swedberg K., McMurray J., et al. Expert consensus document on beta-adrenergic receptor blockers. The Task Force on Beta-Blockers of the European Society of Cardiology. Eur Heart J 25 (2004) 1341-1362
38. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12